We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

174 hedge funds and large institutions have $547M invested in DIPLOMAT PHARMACY, INC. in 2016 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 60 increasing their positions, 54 reducing their positions, and 46 closing their positions.

New
Increased
Maintained
Reduced
Closed

278% more call options, than puts

Call options by funds: $665K | Put options by funds: $176K

11% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 54

6% less funds holding

Funds holding: 185174 (-11)

17% less first-time investments, than exits

New positions opened: 38 | Existing positions closed: 46

62% less capital invested

Capital invested by funds: $1.44B → $547M (-$891M)

Holders
174
Holders Change
-11
Holders Change %
-5.95%
% of All Funds
4.35%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
38
Increased
60
Reduced
54
Closed
46
Calls
$665K
Puts
$176K
Net Calls
+$489K
Net Calls Change
+$41K
Name Holding Trade Value Shares
Change
Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$5.68M +$3.23M +173,460 +63%
SCP
27
Sandhill Capital Partners
New York
$5.33M +$981K +52,679 +14%
SCA
28
Summit Creek Advisors
Minnesota
$4.53M +$1.17M +62,830 +21%
Renaissance Technologies
29
Renaissance Technologies
New York
$4.28M +$6.32M +339,500 New
Principal Financial Group
30
Principal Financial Group
Iowa
$3.96M -$149K -7,984 -2%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$3.83M +$222K +11,902 +4%
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$3.79M +$5.61M +301,215 New
Thrivent Financial for Lutherans
33
Thrivent Financial for Lutherans
Minnesota
$3.33M +$4.5M +241,760 +1,092%
TCIM
34
TIAA CREF Investment Management
New York
$3.02M +$964K +51,761 +28%
Ameriprise
35
Ameriprise
Minnesota
$2.99M -$1.43M -76,834 -24%
GC
36
Guggenheim Capital
Illinois
$2.95M +$4.36M +234,195 New
BIM
37
BlackRock Investment Management
Delaware
$2.87M +$692K +37,168 +19%
Bank of America
38
Bank of America
North Carolina
$2.85M +$2M +107,294 +90%
Russell Investments Group
39
Russell Investments Group
United Kingdom
$2.73M +$3.95M +212,302 New
Fidelity Investments
40
Fidelity Investments
Massachusetts
$2.65M -$16.2M -867,423 -81%
O
41
OppenheimerFunds
New York
$2.56M -$3.77M -202,296 -50%
ARTA
42
A.R.T. Advisors
New York
$2.32M +$3.03M +162,600 +746%
Charles Schwab
43
Charles Schwab
California
$1.96M -$149K -7,975 -5%
RG
44
Redmile Group
California
$1.93M +$2.86M +153,317 New
Goldman Sachs
45
Goldman Sachs
New York
$1.81M +$1.47M +78,871 +121%
Barclays
46
Barclays
United Kingdom
$1.78M +$1.75M +94,104 +200%
TA
47
Teachers Advisors
New York
$1.65M +$1.03M +55,560 +73%
TCM
48
Tekla Capital Management
Massachusetts
$1.64M +$802K +43,060 +49%
Two Sigma Investments
49
Two Sigma Investments
New York
$1.55M +$2.29M +122,762 New
Two Sigma Advisers
50
Two Sigma Advisers
New York
$1.51M +$2.23M +119,757 New

DPLO Hedge Fund Activity: Q4 2016 in Review

174 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2016, worth a combined $547M — down 62% from $1.44B a quarter earlier.

Sellers outnumbered buyers: 46 funds closed out of DPLO and 38 opened new positions — a net loss of 8 holders — while 54 trimmed existing stakes and 60 added.

The largest buyer was Millennium Management, adding an estimated $14.5M. The largest seller was Wells Fargo, cutting an estimated $44.8M.

  • 174 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2016, down from 185 in Q3 2016.
  • Funds reported $547M of DIPLOMAT PHARMACY, INC. stock for Q4 2016, down 62% quarter-over-quarter.
  • 38 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2016 and 46 closed out, a net change of -8 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2016 was Millennium Management, an estimated $14.5M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q4 2016 was Wells Fargo, an estimated $44.8M sold.

Based on aggregated 13F filings for Q4 2016.